Compares two stenting approaches in heart attack patients with multivessel coronary disease
Tests treating all narrowed heart arteries versus only the artery causing the heart attack.
Plain-language title generated from the registry record
Registry title: Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
Key facts
- Where
- Graz, Innsbruck, and Vienna, AustriaSee the 3 sites
Where in Austria
- LKH Univ. Klinikum Graz, Clinical Department of CardiologyGraz, AustriaNot yet recruiting
- Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin IIIInnsbruck, AustriaNot yet recruiting
- Klinik Ottakring, 3. medizinische AbteilungVienna, AustriaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Leipzig Heart Science gGmbH
- Trial code
- NCT05786131
- Record updated
- 16 January 2025
- Original description
Prospective, randomized, controlled, multicenter, open-label trial to study whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease.Read full original descriptionShow less
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI (-COMPLETE-NSTEMI-)
Prospective, randomized, controlled, multicenter, open-label trial to study whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease.
Inclusion: NSTEMI as suggested by high-sensitivity troponin algorithms; Multivessel coronary artery disease; Identifiable culprit lesion; Informed consent.
Exclusion: Prior coronary artery bypass graft; Indication for coronary artery bypass graft surgery; Type 2 myocardial infarction; Age <18 years; Cardiogenic shock; Sustained ventricular tachycardia (VT) or ventricular fibrillation (VF); Contraindication for coronary revascularization; Non-culprit lesion located in the left main coronary artery; Co-morbidity with life expectancy less than 6 months; Pregnancy and breast feeding period.